The Defense Health Agency awarded a $872,914 Project Grant to The Administrators of Tulane Educational Fund (Tulane University) under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on September 1, 2024, will support research to investigate mast cell activation as a mediator of persistent neurological symptoms partly mediated through a novel matrix metalloproteinase. The research aims to improve understanding and treatment of these neurological conditions, which have relevance for military service members and the broader public. Tulane University, a private university located in New Orleans, Louisiana, has extensive experience conducting medical research for federal agencies through grants and contracts.
Generated 2/25/25, 4:39 AM